Clinical trials
Observational Cardiovascular Diseases trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2009 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Unknown status | 6 |
| Recruiting | 5 |
| Active, not recruiting | 4 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medical University Innsbruck | 3 |
| Abbott Medical Devices | 2 |
| Institut für Pharmakologie und Präventive Medizin | 2 |
| VASCage GmbH | 2 |
| AIT Austrian Institute of Technology GmbH | 1 |
| Bayer | 1 |
| Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | 1 |
| German Federal Institute for Risk Assessment | 1 |
| Heidelberg University | 1 |
| Medtronic | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 25 |
| Heart Diseases | 5 |
| Atherosclerosis | 4 |
| Coronary Artery Disease | 4 |
| Heart Failure | 3 |
| Myocardial Infarction | 3 |
| Vascular Diseases | 3 |
| Diabetes Mellitus | 2 |
| Heart Valve Diseases | 2 |
| Inflammation | 2 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.